Background {#Sec1}
==========

With increasing production of biodiesel, a large amount of glycerol is produced as an inevitable byproduct \[[@CR1]\]. Significant glycerol surplus has led to a drastic decrease in glycerol prices over the past few years, which makes it an ideal feedstock for the production of high-value products \[[@CR1]--[@CR3]\]. The main drawback of glycerol utilization in *Escherichia coli* is the relatively low carbon source consumption rate, cell growth, and productivity \[[@CR4]\]. The main reason for this is the allosteric inhibition of the rate-limiting GLPK by FBP and EIIA^Glc^ under aerobic conditions \[[@CR5]--[@CR8]\]. FBP and EIIA^Glc^ both act to reduce *v*~*max*~ of GLPK, which displays a dimer--tetramer equilibrium in solution \[[@CR6]\]. FBP acts both to promote dimer--tetramer assembly and to inactivate the tetramers \[[@CR7]\]. The crystal structure of the EIIA^Glc^:GLPK complexes has been determined \[[@CR8]\]. GLPK with bound glycerol and ADP forms tetramers in which each GLPK subunit interacts with one EIIA^Glc^ molecule, and the association of the two proteins forms a novel intermolecular binding site for Zn (II) \[[@CR9]\]. Genetic modification of the *glpK* gene has resulted in the change in this enzyme that is insensitive to FBP and EIIA^Glc^, allowing improved the glycerol consumption rate \[[@CR10], [@CR11]\]. Another obstacle to glycerol utilization is the shortage of NADPH formation because minimal glycolytic flux is reverted from GAP upwards to the oxidative pentose phosphate (PP) pathway. Because NADPH is an important cofactor needed for the production of useful metabolites, co-fermentation of glycerol with glucose has been proposed as an efficient process \[[@CR4], [@CR12], [@CR13]\], especially for promoting 1,3-propanediol fermentation for the industrial scale production by DuPont \[[@CR14]\]. However, glucose utilization prevents the metabolism of glycerol because of carbon catabolite repression (CCR) \[[@CR15]\].

The central players in CCR in *E. coli* are the transcriptional activator Crp, cAMP receptor protein, the signal metabolite cAMP, Cya, and the phosphorylation system (PTS); these systems are involved in transport and/or phosphotransferase reactions of carbohydrates \[[@CR15]\]. The PTS in *E. coli* consists of two common cytoplasmic proteins, EI, encoded by *ptsI*, and HPr, encoded by *ptsH*, as well as carbohydrate-specific EII complexes encoded by *crr* and *ptsG* \[[@CR16]\]. One metabolic engineering strategy to relax CCR is the inactivation of PTS genes \[[@CR13], [@CR17], [@CR18]\]. The part PEP not consumed in glucose transport was canalized to shikimate pathway \[[@CR17]\], which is a very important route for the synthesis of aromatic amino acids and natural products \[[@CR19]\]. Therefore, we constructed a CCR-negative Δ*ptsGglpK\** mutant by both blocking a key glucose transporter gene *ptsG* and replacing the native *glpK* with *glpK22* from *E. coli* Lin 43 to enhance the glycerol conversion \[[@CR12]\]. This mutant can co-consume glycerol and glucose with a faster glycerol assimilation rate than glucose assimilation rate \[[@CR12]\]. To reveal the metabolic potential of the Δ*ptsGglpK\** mutant, it is necessary to understand its flux distributions and regulation of the co-metabolism of glycerol and glucose in the mutant.

The fluxome is the final functional output of cell metabolism, and is controlled by genetic regulation, enzyme capability, substrate availability, natural allostery, and metabolic network structures \[[@CR20], [@CR21]\]. ^13^C metabolic flux analysis (^13^C-MFA) can accurately determine the fluxes in a metabolic network, which is the most informative tool in quantifying the cellular carbon and energy metabolism and is useful in identifying rate-controlling enzymes \[[@CR21]--[@CR23]\]. ATP and its products ADP/AMP are key regulatory molecules that control enzyme activities in central metabolisms. The limitation of ATP prevents the host from achieving high carbon yields and metabolite production rates. ^13^C-MFA can profile carbon fluxes through most energy generation/consumption pathways, which is the only tool to quantify this problem \[[@CR24]\]. Various studies have been reported elucidating ^13^C-MFA using single-labeled substrate, while a limited number of investigations have been reported performing labeling experiments using multiple isotopic tracers \[[@CR25], [@CR26]\]. For instance, the tracer mixture, \[1,2-^13^C\]glucose and \[U-^13^C\]glutamine led to flux estimates of superior quality in both glycolysis and the TCA cycle in mammalian cells \[[@CR25]\].

This study investigated the co-metabolism of glycerol and glucose in *E. coli*, and elucidated the metabolic potential of the Δ*ptsGglpK\** mutant as a chassis for biosynthesis from cheap feedstock. ^13^C-MFA provided rigorous comparison of cell fluxomes between the wild-type and the mutant strain using well-controlled chemostat cultures: (1) various growth rates could be realized by changing the dilution rate; and (2) cell metabolism could be maintained in a metabolic steady-state during labeling experiment \[[@CR27], [@CR28]\]. To complement the fluxome studies, we also examined the transcriptional levels of key genes and intracellular pyridine nucleotide pools.

Results {#Sec2}
=======

Fermentation characteristics of the wild type and the Δ*ptsGglpK\** mutant {#Sec3}
--------------------------------------------------------------------------

Figure [1](#Fig1){ref-type="fig"} shows the batch fermentation characteristics of the wild-type *E. coli* (BW25113) and the Δ*ptsGglpK\** mutant. The wild-type strain consumed glucose and glycerol sequentially owing to CCR (Fig. [1](#Fig1){ref-type="fig"}a), while the Δ*ptsGglpK\** mutant co-metabolized both glucose and glycerol with faster glycerol consumption than glucose consumption (Fig. [1](#Fig1){ref-type="fig"}b; Additional file [1](#MOESM1){ref-type="media"}a). By modulating GLPK and the deletion of *ptsG*, the specific glycerol consumption rate in the Δ*ptsGglpK\** mutant was 2.7-fold higher than that in the wild-type strain. To understand the co-metabolism of glycerol and glucose in the Δ*ptsGglpK\** mutant, a detailed analysis was performed in continuous cultures.Fig. 1Batch fermentation characteristics of *E. coli* BW25113 (**a**) and the Δ*ptsGglpK\** mutant (**b**). Data represent the mean ± SD from three independent cultures

Table [1](#Tab1){ref-type="table"} summarizes the fermentation characteristics of the two strains in the continuous cultures at dilution rates of 0.1 and 0.35 h^−1^. The two strains showed similar fermentation characteristics at the dilution rate of 0.1 h^−1^ in terms of the specific glucose consumption rate, the specific glycerol consumption rate, and biomass concentration without acetate formation. The fermentation characteristics were quite different at the dilution rate of 0.35 h^−1^. In the wild type, more glucose was catabolized than glycerol. The specific glucose consumption rate was 7.2 times higher than that at the lower dilution rate, while the specific glycerol consumption was decreased slightly. In the Δ*ptsGglpK\** mutant, more glycerol was catabolized than glucose (more than tenfold higher). The specific glycerol consumption rate was more than sevenfold higher at the higher dilution rate compared with that at the lower dilution rate, while the specific glucose consumption rate was similar. The biomass concentration was reduced and acetate overflow was significant in both strains at the higher dilution rate. At the dilution rate of 0.35 h^−1^, the specific glucose consumption rate was decreased by 84.7 %, the specific glycerol consumption rate was increased 8.0-fold, and the specific acetate formation rate was increased 1.3-fold in the Δ*ptsGglpK\** mutant compared with the wild type.Table 1Continuous fermentation characteristics of *E. coli* BW25113 and the ∆*ptsGglpK\** mutantStrainDilution rate (h^−1^)Specific glucose consumption rate (mmol/g/h)Specific glycerol consumption rate (mmol/g/h)Specific acetate formation rate (mmol/g/h)Biomass (g/L)Wild type0.11.03 ± 0.052.01 ± 0.1001.08 ± 0.05∆*ptsGglpK\**0.10.96 ± 0.041.87 ± 0.0901.15 ± 0.05Wild type0.357.43 ± 0.371.72 ± 0.086.97 ± 0.350.52 ± 0.02∆*ptsGglpK\**0.351.14 ± 0.0513.90 ± 0.629.13 ± 0.430.46 ± 0.01Data represent the mean ± SD from three independent cultures

Metabolic flux analysis {#Sec4}
-----------------------

Figure [2](#Fig2){ref-type="fig"} shows the metabolic flux distributions in chemostat cultures of the wild-type strain and the Δ*ptsGglpK\** mutant grown on \[1,3-^13^C\]glycerol and \[1-^13^C\]glucose. In the present study, \[1-^13^C\]glucose was used to identify the flux ratio between the PP pathway and glycolysis at the G6P node, while \[1,3-^13^C\]glycerol was used to discriminate the labeling patterns originating from labeled glucose. The measured mass isotopomer distribution (MDV) of proteinogenic amino acids and the simulated MDV coincided well (Additional file [2](#MOESM2){ref-type="media"}), indicating a good fit and high flux precision. The exchange coefficients are listed in Additional file [3](#MOESM3){ref-type="media"}. The flux patterns resemble those of glucose-feeding for the upper part of glycolysis and the PP pathway, and those of both glucose and glycerol co-feeding for the other parts of central metabolism.Fig. 2Metabolic flux distributions of *E. coli* BW25113 (**a**) and the Δ*ptsGglpK\** mutant (**b**). Fluxes shown are absolute values (mmol/g/h) (flux ± SD). *Numbers* represent the fluxes at dilution rates of 0.1 (*top*) and 0.35 h^−1^ (*bottom*)

First, we compared flux distributions for the two strains at the dilution rate of 0.1 h^−1^. The fluxes were the similar, consistent with the fermentation characteristics. Second, we compared the effects of the dilution rate on the flux distributions of the two strains. In the wild type, as the dilution rate was increased, the absolute fluxes through the PP pathway, glycolytic pathway, anaplerotic pathway and the TCA cycle significantly increased, while the flux through the glyoxylate shunt became negligible. However, the relative distribution of the flux through the TCA cycle decreased from 83 to 47 % (normalized by the substrate consumption rate), while the flux into acetate formation increased. In the Δ*ptsGglpK\** mutant, the absolute fluxes through the PP pathway, glycolytic pathway, and anaplerotic pathway were also enhanced, while the absolute flux through the TCA cycle was 17 % lower than that at the dilution rate of 0.1 h^−1^. The relative flux distribution through the TCA cycle significantly decreased, from 79 to 12 %, while the flux into acetate formation increased. Last, we compared the flux distributions for the two strains at the dilution rate of 0.35 h^−1^. Striking differences were seen between the two strains: in the Δ*ptsGglpK\** mutant as compared with the wild-type strain: (1) the flux through phosphoglucose isomerase decreased by 98.1 %; (2) the flux through GLPDH increased 8.1-fold; (3) the flux through the TCA cycle flux decreased by 57.6 %; and (4) the transhydrogenation flux was reversed, from NADPH → NADH to NADH → NADPH.

Intracellular pyridine nucleotide and ATP pools {#Sec5}
-----------------------------------------------

The cofactors such as NADH, FADH~2~ and NADPH play important roles in regulating redox relevant reactions. NADH/FADH~2~ are involved in ATP generation of oxidative phosphorylation \[[@CR29]\], while the NADPH is essential for anabolism \[[@CR30]\]. Table [2](#Tab2){ref-type="table"} compares the intracellular pyridine nucleotide and ATP pools of the two strains in two chemostat cultures. At the dilution rate of 0.1 h^−1^, the two strains had the similar intracellular pyridine nucleotide and ATP pools. When the dilution rate was increased, the NADPH and NADP^+^ levels increased (*P* \< 0.01 for both) without affecting the NADPH/NADP^+^ ratio in the wild-type strain. In addition, the NADH and NAD^+^ pools and the NADH/NAD^+^ ratio increased (*P* \< 0.01 for all) in this strain. In the Δ*ptsGglpK\** mutant, the NADPH level and the NADPH/NADP^+^ ratio decreased (*P* \< 0.01 for both), while the concentrations of NADH and NAD^+^ and the NADH/NAD^+^ ratio increased (*P* \< 0.01 for all) with the increasing dilution rate. The concentrations of ATP increased at the dilution rate of 0.35 h^−1^ compared with 0.1 h^−1^ in both strains (*P* \< 0.01 for both). Compared with the wild-type strain at the dilution rate of 0.35 h^−1^, the NADPH, NADP^+^, NAD^+^ and ATP concentrations and the NADPH/NADP^+^ ratio were lower (*P* \< 0.01 for all), and the NADH level and the NADH/NAD^+^ ratio were higher (*P* \< 0.1 and *P* \< 0.01) in the Δ*ptsGglpK\** mutant at the same dilution rate. The decreased NADPH/NADP^+^ and increased NADH/NAD^+^ ratios indicated the alteration of the cellular redox state in the Δ*ptsGglpK\** mutant.Table 2Comparison of pyridine nucleotide and ATP pools of *E. coli* BW25113 and the Δ*ptsGglpK\** mutantStrainDilution rate (h^−1^)NADPH (nmol/mg)NADP^+^ (nmol/mg)NADPH/NADP^+^NADH (nmol/mg)NAD^+^ (nmol/mg)NADH/NAD^+^ATP (nmol/mg)Wild type0.10.59 ± 0.030.45 ± 0.021.33 ± 0.090.43 ± 0.021.33 ± 0.060.32 ± 0.021193 ± 130∆*ptsGglpK\**0.10.59 ± 0.020.45 ± 0.011.33 ± 0.070.43 ± 0.021.38 ± 0.070.31 ± 0.02953 ± 131Wild type0.350.77 ± 0.040.67 ± 0.031.16 ± 0.081.39 ± 0.062.76 ± 0.130.50 ± 0.0311,784 ± 583∆*ptsGglpK\**0.350.35 ± 0.030.43 ± 0.020.80 ± 0.061.52 ± 0.072.17 ± 0.100.70 ± 0.052378 ± 213

Relative gene transcription levels {#Sec6}
----------------------------------

Figure [3](#Fig3){ref-type="fig"} shows the gene expression data measured by qRT-PCR. In the wild-type strain, the transcription level of the global regulator gene *crp* was downregulated, while *arcA* was upregulated, at the dilution rate of 0.35 h^−1^ as compared with 0.1 h^−1^. Crp induces expression of its target genes, which include transporters and other genes in the TCA cycle, gluconeogenesis and acetate utilization pathway, upon allosteric activation through high cAMP concentrations \[[@CR31], [@CR32]\]. ArcA represses many genes involved in the TCA cycle and electron transport \[[@CR33]\]. In accordance with the repression of *crp*, the transcription level of the acetate utilization pathway gene *acs* was downregulated (Additional file [4](#MOESM4){ref-type="media"}). In accordance with the repression of *crp* and the activation of *arcA*, the transcription levels of *gltA*, *icdA* and *sdhA* in the TCA cycle were downregulated (Additional file [4](#MOESM4){ref-type="media"}). The transcription levels of *zwf* and *gnd* in the oxidative PP pathway were upregulated. In the Δ*ptsGglpK\** mutant, the changing patterns of these genes were similar to what was observed for the wild-type strain with the increasing dilution rate (Fig. [3](#Fig3){ref-type="fig"}b). In addition, *pntA* showed a higher expression level while *udhA* showed a lower expression level compared with 0.1 h^−1^, implying that excess NADH may be converted to NADPH through the transhydrogenase reaction. Figure [3](#Fig3){ref-type="fig"}c compares gene expression levels in the Δ*ptsGglpK\** mutant with the wild-type strain at the dilution rate of 0.35 h^−1^. The transcription levels of global regulator genes *crp* and *arcA* were upregulated. In accordance with the increase in *crp* expression, the transcription levels of transporter genes *glpFK* (glycerol), *rbsB* (ribose), *mglB/galP* (galactose), *araF* (arabinose), *xylF* (xylose), and *gatA* (galactitol), gluconeogenic genes *pckA* and *ppsA*, and acetate utilization pathway gene *acs* were upregulated (Additional file [4](#MOESM4){ref-type="media"}). In the *E. coli* PTS^−^ strains, glucose was probably transported through GalP and MglBAC systems \[[@CR34]\]. The upregulation of *glpFK* correlates to the increased glycerol consumption rate in the mutant. The overexpression of *glpFK* was also observed in the strain JM101 grown on glycerol as compared to glucose \[[@CR35]\]. Compared with the wild type at the dilution rate of 0.35 h^−1^, the transcription levels of *gltA*, *icdA*, *sdhA* and *udhA* were downregulated, while the transcription level of *pntA* was upregulated in the mutant at the same dilution rate. The repression of the TCA cycle was higher in the Δ*ptsGglpK\** mutant than the wild-type strain at the dilution rate of 0.35 h^−1^, indicating that the repression by ArcA was more than the activation by Crp. Compared with the wild type at the dilution rate of 0.35 h^−1^, the transcription levels of *pta* and *ackA* were upregulated, while *poxB* was downregulated in the Δ*ptsGglpK\** mutant at the same dilution rate. This indicates that acetate is mainly synthesized by phosphotransacetylase/acetate kinase pathway in the mutant.Fig. 3Fold changes of transcription levels of selected genes. **a** *E. coli* BW25113 at the dilution rate of 0.35 h^−1^ compared with 0.1 h^−1^. **b** The Δ*ptsGglpK\** mutant at the dilution rate of 0.35 h^−1^ compared with 0.1 h^−1^. **c** The Δ*ptsGglpK\** mutant compared with the wild type at the dilution rate of 0.35 h^−1^

Discussion {#Sec7}
==========

Central metabolism and CCR {#Sec8}
--------------------------

In general, the Δ*pts* mutant has much slower growth without acetate overflow due to the limitation of glucose uptake \[[@CR16], [@CR32], [@CR34], [@CR36]\]. By overexpression of glycerol conversion pathway, the Δ*ptsGglpK\** mutant can recover similar growth rate in bioreactors to the wild type if both glycerol and glucose were supplied. At the dilution rate of 0.35 h^−1^, the acetate formation rate in the Δ*ptsGglpK\** mutant becomes even higher than the wild-type strain, indicating the re-organization of carbon and energy (ATP) metabolism for fast biomass production when glucose and glycerol are sufficient. To further elucidate this observation, ^13^C-MFA provides direct information on intracellular flux rerouting and offers great insight into the co-mechanism of glycerol and glucose usage. At the dilution rate of 0.1 h^−1^, the wild type and Δ*ptsGglpK\** mutant strains showed similar fermentation characteristics, intracellular pyridine nucleotide pools, and flux distributions, and CCR was rarely observed without acetate overflow. Since low dilution rate mimics the late stationary phase because of carbon source limitation, this drives *E. coli* cells to reduce its glycolytic flux and scavenge any possible carbon sources including acetate \[[@CR37]\]. Similar to *E. coli* growing at the low dilution rate, other slow growing bacteria with weak glycolytic fluxes, such as *Corynebacterium* and *Rhodococcus* \[[@CR38], [@CR39]\], also showed no CCR without acetate overflow.

As the dilution rate was increased, the improved carbon source uptake changed the overall flux magnitude, resulting in increased absolute flux values except for the TCA cycle in the Δ*ptsGglpK\** mutant. The fluxes through the PP pathway, glycolytic pathway, and anaplerotic pathway significantly increased to fulfill the demand for biomass synthesis. High carbon source consumption evokes CCR, and a higher fraction of the consumed carbon source was secreted as overflow metabolites \[[@CR16], [@CR40]\]. In both strains, the decrease in *crp* expression demonstrated that CCR was activated. As a consequence, cAMP-Crp dependent regulation of *acs* and *gltA* was downregulated. This result is consistent with a previous study on *E. coli* using advanced continuous cultivation methods \[[@CR32]\]. The downregulation of *gltA* was in line with the relative flux results, which caused acetate to be accumulated (Additional file [5](#MOESM5){ref-type="media"}). Because the main carbon source consumed in the wild-type strain is glucose, the metabolic characteristics are similar to those when using glucose as the sole carbon source. In the Δ*ptsG* mutant, EIIA^Glc^-P accumulates and activates Cya. Then the level of cAMP is enhanced, which increases the level of the cAMP-Crp and activates the transcription of *crp* \[[@CR41]\]. Finally, CCR is relaxed and co-consumption of glucose--pentose can be attained \[[@CR42]\]. The glycerol metabolism partially induces catabolite repression \[[@CR43]\], and the *glpK* mutant strains enhances the power of glycerol to exert this repression \[[@CR40], [@CR44]\]. Glycerol or Gly3P cause strong repression of *malT*, although phosphorylation of EIIA^Glc^ is only slightly lowered \[[@CR43]\]. The proposed mechanism is that Gly3P inhibits EIIA^Glc^-P-mediated stimulation of Cya, thus lowering the cAMP concentrations \[[@CR43]\]. Because the inhibition of GLPK by FBP and EIIA^Glc^ was relieved in the *glpK* mutant \[[@CR10]\], fast glycerol consumption increased the transfer of phosphoryl groups from EIIA^Glc^ to produce Gly3P. The resulting decrease in EIIA^Glc^-P in turn reduced Cya activity and cAMP production \[[@CR40]\]. Together, deletion of *ptsG* and replacement of *glpK* caused transcriptional repression to a lesser extent than the wild-type strain, as shown by the upregulations of *crp*, transporter genes, gluconeogenic genes and *acs* in the Δ*ptsGglpK\** mutant compared with the wild type growing at the dilution rate of 0.35 h^−1^ (Fig. [2](#Fig2){ref-type="fig"}c). This mutant can co-utilize mixtures of glycerol--xylose and glycerol--galactose, but it cannot co-utilize the mixture of glycerol-acetate (Additional file [1](#MOESM1){ref-type="media"}).

Cofactors NADH and FADH~2~ metabolism {#Sec9}
-------------------------------------

The cofactors balance can be estimated from the metabolic fluxes \[[@CR45], [@CR46]\]. Table [3](#Tab3){ref-type="table"} summarizes the specific rates of the formation and consumption of cofactors derived from the flux data given in Fig. [2](#Fig2){ref-type="fig"}. The major pathway enzymes for supplying NADH are GAPDH and PDH in glycolysis, AKGDH and MDH in the TCA cycle, and transhydrogenase (UdhA) \[[@CR29]\]. SDH and GLPDH are the main enzymes for the genesis of FADH~2~ \[[@CR5], [@CR47]\]. At the dilution rate of 0.1 h^−1^, the fluxes from the glycolysis accounted for 51 % of the NADH formation, while those from the TCA cycle accounted for 35 % of the NADH formation in the two strains. When the dilution rate was increased, the glycolytic flux increased, producing a large amount of NADH from the glycolysis in both strains. In the case of the Δ*ptsGglpK\** mutant, FADH~2~ formation at GLPDH became significant as the glycerol consumption rate increased at the dilution rate of 0.35 h^−1^ (Table [3](#Tab3){ref-type="table"}). Increased NADH and FADH~2~, as major donors to the electron transport chain, create a highly oxidative environment which is detrimental to aerobically growing *E. coli* cells \[[@CR48]\]. NADH allosterically inhibits CS and ICDH \[[@CR49]\]. In addition, redox state as a signal activates the ArcA regulatory system. Because the NADH level and the NADH/NAD^+^ ratio were the highest we observed in the Δ*ptsGglpK\** mutant growing at the dilution rate of 0.35 h^−1^, the inhibition of the TCA cycle was more severe than in the wild type, as demonstrated by the upregulation of *arcA* and the downregulation of *gltA*, *icdA* and *sdhA* (Fig. [3](#Fig3){ref-type="fig"}c). This suggests that ArcA, more than Crp, regulated the expression levels of the TCA cycle genes when glycerol was being consumed as the main carbon source at the higher dilution rate (Fig. [4](#Fig4){ref-type="fig"}). In addition, ArcA exerts a negative control on the TCA cycle fluxes in the aerobic batch culture of *E. coli*, where knockout of ArcA-dependent regulation increased the TCA cycle fluxes by over 60 % \[[@CR50]\]. The higher dilution rate mimics the cell growth phase in batch culture. Therefore, the relative flux through CS in the TCA cycle decreased in both strains with increasing dilution rate. Furthermore, the absolute flux through the TCA cycle increased in the wild type, but decreased in the Δ*ptsGglpK\** mutant, indicating strong repression of the TCA cycle when glycerol was being consumed as the main carbon source at the higher dilution rate. Reduction of the TCA cycle flux limited NADH production: the fluxes from the TCA cycle accounted for 19 and 7 % of the NADH formation in the wild type and Δ*ptsGglpK\** strains at the dilution rate of 0.35 h^−1^, respectively. Consequently, this reduced the oxidative stress caused by the oxidation of NADH and FADH~2~, as also implied by Mailloux et al. \[[@CR48]\]. Meanwhile, the activated transhydrogenase PntAB converted excess NADH to NADPH and reduced redox imbalance.Table 3Estimated production and consumption of cofactors and ATP by *E. coli* BW25113 and the Δ*ptsGglpK\** mutantStrainWild type∆*ptsGglpK\**a NADH Dilution rate (h^−1^)0.10.350.10.35 GLPDH0000 Glycolysis6.7727.646.0926.90 TCA cycle4.676.954.121.30 PP pathway0000 Anaplerotic pathway0.030.330.020.25 Acetate formation0000 Biomass formation0.331.170.331.17 Transhydrogenation1.450.471.17−2.26 Oxidative phosphorylation−13.25−36.57−11.72−28.18b FADH~2~ Dilution rate (h^−1^)0.10.350.10.35 GLPDH2.011.721.8713.90 Glycolysis0000 TCA cycle2.363.802.071.30 PP pathway0000 Anaplerotic pathway0000 Acetate formation0000 Biomass formation0000 Transhydrogenation0000 Oxidative phosphorylation−4.37−5.52−3.94−15.20c NADPH Dilution rate (h^−1^)0.10.350.10.35 GLPDH0000 Glycolysis0000 TCA cycle2.194.342.041.84 PP pathway1.022.120.921.94 Anaplerotic pathway0.030.330.020.25 Acetate formation0000 Biomass formation−1.80−6.30−1.80−6.30 Transhydrogenation−1.45−0.47−1.172.26 Oxidative phosphorylation0000d ATP Dilution rate (h^−1^)0.10.350.10.35 Glucose uptake00−0.96−1.14 Glycerol uptake−2.01−1.72−1.87−13.90 GLPDH0000 Glycolysis5.2513.995.6827.11 TCA cycle2.043.801.881.30 PP pathway0000 Anaplerotic pathway0000 Acetate formation06.9709.13 Biomass formation−2.30−8.05−2.30−8.05 Transhydrogenation0000 Oxidative phosphorylation^a^48.4943.08 Oxidative phosphorylation^b^99.48 Oxidative phosphorylation^c^71.57 Maintenance cost51.47114.4745.5186.37a NADH. b FADH~2~. c NADPH. d ATPAll the fluxes shown are absolute values (mmol/g/h)^a^The *P/O* ratios for NADH and FADH~2~ were 3 and 2, respectively^b^The *P/O* ratios for NADH and FADH~2~ were 2.5 and 1.5, respectively^c^The *P/O* ratios for NADH and FADH~2~ were 2 and 1, respectivelyFig. 4Proposed mechanism of the metabolic effects of *ptsG* and *glpK* mutations in *E. coli*

Cofactor NADPH metabolism {#Sec10}
-------------------------

The major NADPH-generating reactions are G6PDH and 6PGDH in the PP pathway, NADP^+^-dependent ICDH in the TCA cycle, and transhydrogenase (PntAB and UdhA) \[[@CR45]\]. At the dilution rate of 0.1 h^−1^, the TCA cycle contributed a large fraction of the supply of NADPH in both strains. At the lower dilution rate, the NADPH required for anabolic demand is small, so the transhydrogenase flux converted excess NADPH to NADH, 45 % for the wild type, and 39 % for the Δ*ptsGglpK\** mutant, respectively. This result is consistent with a previous study on *E. coli* in glucose-limited chemostat cultures. When the dilution rate was increased, the NADPH requirement for biosynthesis increased. The activity of both G6PDH and 6PGDH has been reported to be growth rate dependent; here, we consider the activation of the oxidative PP pathway to be due to the NADPH requirement for anabolic demand, as demonstrated by the increased transcriptional levels of *zwf* and *gnd* in both strains. For the wild type growing at the dilution rate of 0.35 h^−1^, catabolic NADPH production via the PP pathway and TCA cycle almost matched the anabolic demands. For the Δ*ptsGglpK\** mutant growing at the dilution rate of 0.35 h^−1^, these two sources of NADPH seemed to be insufficient. Although about 85 % of glucose passed through the oxidative PP pathway, little glycerol was channeled to the upper glycolysis and PP pathway. Minimal flux from GAP upwards to G6P was also observed in *B. subtilis* grown on glycerol \[[@CR51]\]. Thus, the flux from the oxidative PP pathway accounted for 31 % of the NADPH supply in the Δ*ptsGglpK\** mutant at the dilution rate of 0.35 h^−1^. Because of NADH and FADH~2~ accumulation, the TCA cycle was significantly repressed and accounted for only 29 % of the NADPH supply in the Δ*ptsGglpK\** mutant at the dilution rate of 0.35 h^−1^. There was about a 36 % gap to be filled to fulfill the demand for NADPH. The transhydrogenation reaction served this purpose, as also noted by Sauer et al. \[[@CR45]\]. In line with the flux results, the transcriptional level of *pntA* was upregulated in the Δ*ptsGglpK\** mutant at the dilution rate of 0.35 h^−1^ compared with the case at 0.1 h^−1^, as well as to the wild type at the dilution rate of 0.35 h^−1^. It has also been reported that expression of *pntAB* was induced when there was a demand for NADPH, and *pntAB* was required for optimal growth on carbon sources whose metabolism does not directly generate NADPH \[[@CR30]\].

Energy (ATP) metabolism {#Sec11}
-----------------------

Based on fluxes, the specific ATP formation and consumption rates were estimated in the two strains (Table [3](#Tab3){ref-type="table"}d). *E. coli* can produce ATP from either oxidative phosphorylation or substrate-level phosphorylation such as acetate formation \[[@CR52]\]. Since the molar ATP yield from respiration is higher than that from substrate-level phosphorylation, the former is much more efficient than the latter \[[@CR53]\]. Since the cells exhibited fully respiratory growth under carbon source limited state \[[@CR45]\], we assumed the maximum *P/O* ratio to be the moles of ATP formed per oxygen atom: NADH → 3 ATP and FADH~2~ → 2 ATP at the dilution rate of 0.1 h^−1^ \[[@CR54]\]. Based on this assumption, the ATP formation fluxes via oxidative phosphorylation were about 9 times of that via substrate-level phosphorylation in both strains. As the dilution rate was increased, the respiration efficiency was lowered in both strains (Additional file [6](#MOESM6){ref-type="media"}). Holms \[[@CR55]\] also showed that excess glucose (or other highly sufficient carbon sources) inhibited respiration in *E. coli*. Thus, we set the *P/O* ratio to be 2.5 and 1.5 for oxidizing NADH and FADH~2~ at the dilution rate of 0.35 h^−1^. Since the expression levels of respiratory chains genes were more repressed in the Δ*ptsGglpK\** mutant as compared to the wild-type strain (Additional file [6](#MOESM6){ref-type="media"}), we chose the *P/O* ratio to be 2 and 1 for oxidizing NADH and FADH~2~, respectively, in the mutant at the dilution rate of 0.35 h^−1^. In any case, the exact *P/O* ratio per se does not affect the main conclusion of the present work. The ATP provided via oxidative phosphorylation in the Δ*ptsGglpK\** mutant was 28 % lower than that in the wild type. In contrast, more ATP was provided by acetate formation in the Δ*ptsGglpK\** mutant, indicating acetate production became an important source of energy generation through substrate-level phosphorylation. The contribution of ATP from substrate-level phosphorylation was increased from 10 to 14 % in the wild type, while it was increased from 10 to 16 % in the Δ*ptsGglpK\** mutant with the increasing dilution rate.

Acetate overflow is interpreted as a manifestation of the imbalance of carbon uptake/availability and those for energy production and biosynthesis \[[@CR52]\]. Why was ATP less generated in the Δ*ptsGglpK\** mutant, where glycerol consumption was dominant as compared to the wild-type strain, where the glucose consumption was dominant at the dilution rate of 0.35 h^−1^, resulting in more acetate overflow? Firstly, the lower expression levels of respiratory chains genes caused lower *P/O* in the Δ*ptsGglpK\** mutant. This led to the reduction in ATP supply via oxidative phosphorylation. Secondly, less NADPH, which is an integral part of the oxidative energy-generating machinery of aerobic organisms, was produced in the Δ*ptsGglpK\** mutant. NADPH helps maintain the reductive environment necessary for oxidative phosphorylation. Without continual supply of NADPH, production of ATP by oxidative phosphorylation cannot proceed effectively \[[@CR56]\]. Finally, the activity of PntAB is energy dependent \[[@CR45]\], indicating that the Δ*ptsGglpK\** mutant requires more energy input at the dilution rate of 0.35 h^−1^. These could all lead to the decrease of ATP production. As a result, acetate overflow mechanism was activated to provide additional energy supply in the Δ*ptsGglpK\** mutant.

The potential of the Δ*ptsGglpK\** mutant for the production of biofuels and biochemicals {#Sec12}
-----------------------------------------------------------------------------------------

This study has increased our understanding of the physiological implications of the Δ*ptsGglpK\** mutant, where the information obtained by ^13^C-MFA integrated with transcription/metabolite profiling is useful for the effective manipulation and engineering of *E. coli* for the production of biofuels and biochemicals. ^13^C-MFA revealed that glucose shifted flux from the glycolytic pathway to the oxidative PP pathway to increase NADPH availability in the Δ*ptsGglpK\** mutant, demonstrating the benefit of co-utilization of glycerol and glucose for NADPH supply. In our previous work, we engineered an acetol overproducing strain (HJ05) through overexpressing of *yqhD* and silencing of *gapA* from the Δ*ptsGglpK\** mutant \[[@CR12]\]. Because the aldehyde oxidoreductase encoded by *yqhD* utilizes NADPH as a cofactor \[[@CR57]\], NADPH availability is one important factor for the acetol production. Compared with utilization of glycerol as a sole carbon source in the control strain, co-utilization of glycerol and glucose in HJ05 increased NADPH availability and acetol production (1.82 g/L).

This study found that the Δ*ptsGglpK\** mutant showed the increased NADH level and the NADH/NAD^+^ ratio. The excess reducing equivalents could be consumed by converting glycerol to more reduced products under microaerobic conditions, such as ethanol and 1,2-propanediol (1,2-PDO) \[[@CR58], [@CR59]\]. The 1,2-PDO biosynthesis pathways of *E. coli* using glycerol as a carbon source with glucose as a co-substrate are shown in Additional file [7](#MOESM7){ref-type="media"}. The production of 1,2-PDO from glycolytic intermediate DHAP has been well established \[[@CR59], [@CR60]\]. Coupling parts of these strategies with our previous work on the efficient production of acetol (an intermediate upstream of 1,2-PDO synthesis) could be an effective approach to increase 1,2-PDO and lower the NADH level and the NADH/NAD^+^ ratio.

Conclusions {#Sec13}
===========

The present investigation shows the power of ^13^C-MFA using multiple isotopic tracers, applied in this case to the co-metabolism of glucose and glycerol in the *E. coli* Δ*ptsGglpK\** mutant. The Δ*ptsGglpK\** mutant preferentially consumed glycerol by reorganization of its fluxomes: fast glycerol consumption in the Δ*ptsGglpK\** mutant affected the redox NADPH/NADH state and reduced the ATP level, activated the ArcA regulatory system, and repressed the TCA cycle, causing acetate overflow. In addition, glucose shifted flux from the glycolytic pathway to the oxidative PP pathway to increase NADPH availability in the Δ*ptsGglpK\** mutant, demonstrating that additional carbon source is usually required to help provide the cofactor and the production of other products from glycerol which is limited. The Δ*ptsGglpK\** mutant can be used as a platform for the production of high-value products, especially those requiring excess reducing equivalents (such as alcohol biofuels).

Methods {#Sec14}
=======

Strains, culture medium and growth conditions {#Sec15}
---------------------------------------------

The strains used in this study are listed in Table [4](#Tab4){ref-type="table"}. The parental strain *E. coli* BW25113 (CGSC 7636) and *E. coli* Lin 43 (CGSC 5511) containing the *glpK22* allele were obtained from the *E. coli* Genetic Stock Center at the Department of Biology, Yale University. The sequence of the *glpK22* gene was found in GenBank under accession no. U41468 \[[@CR61]\]. The *ptsG* gene in *E. coli* BW25113 (UniProt: P69786) was disrupted by P1 phage transduction \[[@CR62]\].Table 4Strains used in this studyStrainsRelevant genotype or descriptionSource or referenceBW25113*F* ^−^ *λ* ^−^ *rph* ^−*1*^ Δ*araBAD* ~*AH33*~ *lacI* ^*q*^ Δ*lacZ* ~*WJ16*~ *rrnB* ~*T14*~ Δ*rhaBAD* ~*LD78*~ *hsdR514E. coli* Genetic Stock Center from Yale UniversityLin 43Hfr(PO2A) *fhuA22*, *ΔphoA8*, *fadL701*(T2R), *relA1*, *glpR2*(*glp* ^*c*^), *pitA10*, *spoT1*, *glpK22*(fbR), *rrnB*-*2*, *mcrB1*, *creC510E. coli* Genetic Stock Center from Yale UniversityBW25113 Δ*ptsG*BW25113, *ptsG* ^−^This studyBW25113 Δ*ptsGglpK\**BW25113 ∆*ptsG*, *glpK* gene replaced by *glpK22* from strain Lin43This study

The strains were first pre-cultured in LB medium. The subsequent pre-culture, the batch culture, the main culture and the continuous culture were carried out using M9 minimal medium containing of 2 g/L of glucose and 2 g/L of glycerol. In batch cultures in Additional file 1[1](#MOESM1){ref-type="media"}, the M9 medium contained mixtures of 5 g/L of glycerol and 5 g/L of glucose, 2 g/L of glycerol and 2 g/L of xylose, 2 g/L of glycerol and 2 g/L of galactose, and 2 g/L of glycerol and 0.5 g/L of acetate. The M9 minimal medium contained per liter: 6.81 g Na~2~HPO~4~, 2.99 g KH~2~PO~4~, 0.58 g NaCl and 5.94 g (NH~4~)~2~SO~4~. The following components were filter sterilized and then added (per liter) with 1 ml of 1 M MgSO~4~·7H~2~O, 1 ml of 0.1 mM CaCl~2~·2H~2~O, 1 ml of 1 mg/L thiamine HCl and 10 ml of trace element solution containing (per liter): 0.55 g CaCl~2~·2H~2~O, 1.67 g FeCl~3~·6H~2~O, 0.1 g MnCl~2~·4H~2~O, 0.17 g ZnCl~2~·2H~2~O, 0.043 g CuCl~2~·2H~2~O, 0.06 g CoCl~2~·2H~2~O, and 0.06 g Na~2~M~O~O~4~·2H~2~O. The first pre-culture inoculated from the glycerol stock was grown for 8 h of 10 mL LB medium. The subsequent pre-cultivation was performed by transferring 1 mL of culture broth to a 500-mL baffled Erlenmeyer flasks containing 100 mL of M9 medium. After 12 h, cells were harvested, washed and used to inoculate the main culture. The main culture and continuous culture were conducted in a 2-L fermentor with a working volume of 1 L at 37 °C, 500 rpm with an aeration rate of 1.0 vvm. The pH was controlled at 7.0. The dilution rates in the continuous culture were 0.1 and 0.35 h^−1^. Samples for cell growth, extracellular and intracellular metabolites and real-time quantitative PCR were taken at the steady-state condition (after five residence times).

Analytical methods {#Sec16}
------------------

Bacterial growth was monitored by measuring the optical density of the culture broth at 600 nm. Concentrations of glucose, glycerol, xylose, galactose and acetate were measured by high performance liquid chromatography (model 1260, Agilent, Santa Clara, USA) using a cation-exchange column (HPX-87H, Bio-Rad, Hercules, CA) and a differential refractive index (RI) detector. A mobile phase of 5 mM H~2~SO~4~ at 0.5 mL/min flow rate was used and the column was operated at 60 °C.

Quantification of intracellular cofactors and ATP analysis {#Sec17}
----------------------------------------------------------

Intracellular NADP^+^/NADPH, NAD^+^/NADH were determined by using EnzyChrom NADP^+^/NAD Assay^+^/NADPH and NAD kit (BioAssay Systems, Hayward, CA), following the manufacturer's instructions. Intracellular ATP was measured by capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS): Agilent CE capillary electrophoresis system (Agilent Technologies, Germany) and an Agilent G3250AA LC/MSD TOF system (Agilent Technologies, Palo Alto, CA). The measurement conditions have been described elsewhere \[[@CR63]\]. The raw CE-TOFMS data were analyzed using MasterHands software version 2.9 \[[@CR64]\], and the in vivo metabolite concentrations were quantitated. Data represent the average and standard deviation, which was calculated as average of three technical and two biological replicates. Multiple comparisons among a set of experiments were made by one-way analysis of variance (ANOVA) with the level of significance set at *P* \< 0.05.

Quantitative real-time PCR (qRT-PCR) analysis {#Sec18}
---------------------------------------------

Total RNA was isolated using an RNA Extraction Kit (ABigen Corporation, China). Contaminating DNA was removed with RNase-free DNase I (ABigen Corporation, China). The first-strand cDNA was synthesized using PrimeScript™ II 1st Strand cDNA Synthesis Kit (Takara Co. Ltd., China). QRT-PCR was performed with the SYBR^®^ Premix Ex Taq™ Kit (Takara Co. Ltd., China) on an ABI Stepone Real-Time PCR System (Applied Biosystems, USA). The primers used are listed in Additional file [8](#MOESM8){ref-type="media"}, and the housekeeping gene 16S rRNA was used to normalize the gene expression data. The PCR conditions were: 95 °C for 4 min, followed by 35 cycles of denaturation at 95 °C for 15 s, annealing at 57 °C for 15 s, and extension at 72 °C for 20 s. Three biological samples were analyzed, and each sample was analyzed three times. The data were averaged and presented as the mean ± standard deviation. Significant differences were determined by one-way analysis of variance (ANOVA). Statistical significance was defined as *P* \< 0.05.

^13^C-MFA {#Sec19}
=========

The labeling experiments were started after taking samples for cell growth, extracellular and intracellular metabolites and real-time quantitative PCR. The unlabeled feeding medium was replaced by an identical medium, a mixture of 50 % \[1,3-^13^C\]glycerol and 50 % \[1-^13^C\]glucose. GC--MS analyses of proteinogenic amino acids were made as described previously \[[@CR65]\]. In brief, cells were harvested and hydrolyzed in 6 M HCl at 105 °C. The hydrolysate was dried then derivatized using *N*-(*tert*-butyldimethylsilyl)-*N*-methyl-trifluoroacetamide (MTBSTFA) (Sigma-Aldrich, USA). GC--MS analysis was carried out using GC--MS (Hewlett Packard 7890A and 5975C, Agilent Technologies, Santa Clara, CA) equipped with a DB-5MS column (30 m × 0.25 mm × 0.25 μm).

^13^C-MFA was based on the isotopomer mapping matrices (IMMs), and details concerning the general framework of ^13^C-MFA may be found elsewhere \[[@CR39]\]. This most frequently employed isotope tracer method detects in 10--15 protein-bound amino acids. The *E. coli* network model used for flux calculation included glucose metabolism, glycerol metabolism, glycolysis, PP pathway, TCA cycle, glyoxylate shunt, lumped biomass formation and transhydrogenation reaction (Additional file [9](#MOESM9){ref-type="media"}). The 116 and 120 mass isotopomers were used for the dilution rates at 0.1 and 0.35 h^−1^, respectively. Three external fluxes (glucose, glycerol, acetate) were fitted to the model to estimate 17 or 18 free fluxes for the cases of the dilution rates of 0.35 and 0.1 h^−1^, respectively.

For statistical analysis, 500 simulated measurement data sets of mass distribution were generated by addition of normally distributed measurement noise to the simulated measurement data set corresponding to the best fit flux distribution. Then, from the probability distribution of these re-calculated flux distributions, 90 % confidence intervals could be obtained \[[@CR65]\].

Abbreviations {#Sec20}
=============

Metabolites {#Sec21}
-----------

AcCoA: acetyl-CoA; AKG: α-ketoglutarate; CIT: citrate; DHAP: dihydroxyacetone phosphate; E4P: erythrose 4-phosphate; F6P: fructose 6-phosphate; FBP: fructose 1,6-bisphosphate; FUM: fumarate; G6P: glucose-6-phosphate; GAP: glyceraldehyde 3-phosphate; GLX: glyoxylate; Gly3P: glycerol-3-phosphate; ICIT: isocitrate; MAL: malate; OAA: oxaloacetate; 3PG: 3-phosphoglyceric acid; 6PG: 6-phosphogluconolactone; PEP: phosphoenolpyruvate; PYR: pyruvate; R5P: ribose 5-phosphate; RU5P: ribulose 5-phosphate; S7P: sedoheptulose 7-phosphate; SUCCoA: succinyl-CoA; SUC: succinate; X5P: xylulose 5-phosphate.

Proteins (enzymes) {#Sec22}
------------------

AKGDH: α-ketoglutarate dehydrogenase; CS: citrate synthase; Cya: adenylate cyclase; EI: Enzyme I; EII: Enzyme II; G6PDH: glucose-6-phosphate dehydrogenase; GAPDH: glyceraldehyde 3-phosphate dehydrogenase; GLPDH: glycerol-3-phosphate dehydrogenase; GLPK: glycerol kinase; HPr: Histidine-containing protein; ICDH: isocitrate dehydrogenase; MDH: malate dehydrogenase; 6PGDH: 6-phosphogluconolactone dehydrogenase; PDH: pyruvate dehydrogenase; SDH: succinate dehydrogenase.

Genes {#Sec23}
-----

*ackA*: acetate kinase gene; *acs*: acetyl-CoA synthetase gene; *araF*: arabinose ABC transporter gene; *arcA*: anoxic redox control protein gene; *crp*: cyclic AMP receptor; *galP*: galactose permease gene; *gapA*: glyceraldehyde 3-phosphate dehydrogenase gene; *gatA*: galactitol PTS permease gene; *glpF*: glycerol facilitator gene; *glpK*: glycerol kinase gene; *gltA*: citrate synthase gene; *gnd*: 6-phosphogluconate dehydrogenase gene; *icdA*: isocitrate dehydrogenase gene; *mglB*: galactose ABC transporter gene; *pckA*: phosphoenolpyruvate carboxykinase gene; *pntA*: membrane-bound transhydrogenase gene; *poxB*: pyruvate oxidase gene; *ppsA*: phosphoenolpyruvate synthase gene; *pta*: phosphotransacetylase gene; *ptsG*, *ptsHI*: PTS genes; *rbsB*: ribose ABC transporter gene; *sdhA*: succinate dehydrogenase; *udhA*: soluble transhydrogenase gene; *xylF*: xylose transporter gene; *yqhD*: aldehyde oxidoreductase gene; *zwf*: glucose 6-phosphate dehydrogenase gene.

Additional files {#Sec24}
================

10.1186/s13068-016-0591-1 Batch fermentation characteristics of the Δ*ptsGglpK\** mutant using mixtures of carbon sources. **a** Glycerol-Glucose. **b** Glycerol-Xylose. **c** Glycerol-Galactose. **d** Glycerol-Acetate. Data represent the means ± SD from three independent cultures.10.1186/s13068-016-0591-1 Experimentally measured and simulated mass distributions (mol %) of amino acid fragment of *E. coli* BW25113 and the Δ*ptsGglpK\** mutant at the dilution rates of 0.1 and 0.35 h^−1^.10.1186/s13068-016-0591-1 The exchange coefficients in *E. coli* BW25113 and the Δ*ptsGglpK\** mutant at dilution rates of 0.1 and 0.35 h^−1^.10.1186/s13068-016-0591-1 Global regulators and their regulated genes.10.1186/s13068-016-0591-1 The regulation mechanism of the dilution rate on the metabolism of *E. coli* BW25113 (**a**) and the Δ*ptsGglpK\** mutant (**b**).10.1186/s13068-016-0591-1 Fold changes of transcription levels of selected genes. **a** *E. coli* BW25113 at the dilution rate of 0.35 h^−1^ compared with 0.1 h^−1^. **b** The Δ*ptsGglpK\** mutant at the dilution rate of 0.35 h^−1^ compared with 0.1 h^−1^. **c** The Δ*ptsGglpK\** mutant compared with the wild-type at the dilution rate of 0.35 h^−1^. Asterisks indicate the statistical significance level: *P* \< 0.05 (\*). *cyoA* cytochrome bo terminal oxidase subunit II gene; *cydA* cytochrome bd-I terminal oxidase subunit I gene; *gapC* split glyceraldehyde 3-phosphate dehydrogenase C gene; *ndh* NADH dehydrogenase NDH-2 gene; *nuoA* NADH dehydrogenase NDH-1 gene; *pgi* phosphoglucose isomerase gene; *rpiB* ribose-5-phosphate isomerase B gene; *talA* transaldolase A gene.10.1186/s13068-016-0591-1 Metabolic pathways involved in glycerol and glucose dissimilations and biosynthesis of 1,2-propanediol in *E. coli*. Broken lines illustrate multiple steps. *aceE, aceF* pyruvate dehydrogenase genes; *adhE* aldehyde-alcohol dehydrogenase gene; *aldA* lactaldehyde dehydrogenase gene; *dhaKLM* dihydroxyacetone kinase genes; *fbaA, fbaB* fructose bisphosphate aldolase genes; *fucO* 1,2-propanediol reductase gene; *gldA* glycerol dehydrogenase gene; *glk* glucokinase gene; *gloA* glyoxylase type I gene; *gloB* glyoxylase type II gene; *glpD* glycerol-3-phosphate dehydrogenase gene; *ldhA* lactate dehydrogenase gene; *lpdA* lipoamide dehydrogenase gene; *mgsA* methylglyoxal synthase gene; *pflB* pyruvate formate-lyase gene; *pykA, pykF pyruvate kinase gens*; *tpiA* triosephosphate isomerase gene.10.1186/s13068-016-0591-1 Primers used in this study.10.1186/s13068-016-0591-1 Metabolic network model of *E. coli* used for ^13^C-MFA.
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